Published in Support Care Cancer on December 03, 2004
The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil (1987) 4.86
Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA (2000) 3.05
The impact of cancer on the physical function of the elderly and their utilization of health care. Cancer (1997) 2.48
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer (2003) 2.06
The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil (1995) 2.04
The effects of multidimensional home-based exercise on functional performance in elderly people. J Gerontol A Biol Sci Med Sci (2004) 1.97
Outcomes of continuous process improvement of a nutritional care program incorporating serum prealbumin measurements. Nutrition (1997) 1.63
Effects of two models of nutritional intervention on homebound older adults at nutritional risk. J Am Diet Assoc (2003) 1.49
Evaluation of consultation-based rehabilitation for hospitalized cancer patients with functional impairment. Mayo Clin Proc (1999) 1.48
The emerging science of functional assessment: our tool for outcomes analysis. Arch Phys Med Rehabil (1998) 1.33
Cancer anorexia and cachexia. Nutrition (2001) 1.20
Malnutrition, nutritional indices, and early enteral feeding in critically ill children. Nutrition (2001) 1.11
Prealbumin: a marker for nutritional evaluation. Am Fam Physician (2002) 1.07
The efficacy of nutritional assessment and support in cancer surgery. Cancer (1981) 1.05
Relation of disability costs to function: spinal cord injury. Arch Phys Med Rehabil (1999) 1.01
Rehabilitation for the terminal cancer patient. Am J Phys Med Rehabil (1994) 1.00
The influence of protein-calorie malnutrition on quality of life in nursing homes. J Gerontol A Biol Sci Med Sci (2003) 0.98
Outcome of cancer patients receiving home parenteral nutrition. Italian Society of Parenteral and Enteral Nutrition (S.I.N.P.E.). JPEN J Parenter Enteral Nutr (1998) 0.97
Update on anorexia and cachexia. Hematol Oncol Clin North Am (2002) 0.96
Tumor anorexia: causes, assessment, treatment. Recent Results Cancer Res (1991) 0.94
Benefits of nutritional supplementation in free-living, frail, undernourished elderly people: a prospective randomized community trial. J Am Diet Assoc (2002) 0.94
Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol (1995) 0.94
The NIH stroke scale and the FIM in stroke rehabilitation. Stroke (1992) 0.92
Rehabilitation of patients with advanced cancer. Cancer (2001) 0.91
Muscle strength as a predictor of loss of functional status in hospitalized patients. Nutrition (2002) 0.91
Nutritional status of children with solid tumors. Cancer (1999) 0.90
Serum prealbumin predicts survival in hemodialysis and peritoneal dialysis: 10 years of prospective observation. Am J Kidney Dis (2001) 0.89
Exercise, cachexia, and cancer therapy: a molecular rationale. Nutr Cancer (2002) 0.87
The syndrome of anorexia-cachexia. Curr Opin Oncol (1999) 0.87
The effect of a liquid nutrition supplement on body composition and physical functioning in elderly people. Clin Nutr (2003) 0.86
Functional task benchmarks for stroke rehabilitation. Arch Phys Med Rehabil (1998) 0.85
Prealbumin measurement as a screening tool for protein calorie malnutrition in emergency hospital admissions: a pilot study. Clin Invest Med (1999) 0.81
Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer. Lung Cancer (1997) 0.80
Malnutrition and the role of nutritional support for radiation therapy patients. Recent Results Cancer Res (1988) 0.77
Early determination of nutritional problems in pediatric cancer patients. Turk J Pediatr (1997) 0.77
The American Dietetic Association 79th annual meeting. San Antonio, Texas, October 21-24, 1996. Abstracts. J Am Diet Assoc (1996) 0.76
Combined modalities in the treatment of head and neck cancers. Semin Oncol (1995) 0.76
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol (2013) 5.07
Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain (2006) 4.96
Availability and integration of palliative care at US cancer centers. JAMA (2010) 4.51
Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol (2009) 3.36
Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer (2009) 2.58
Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol (2003) 2.38
Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer (2011) 2.15
Dehydration in cancer patients: to treat or not to treat. J Support Oncol (2004) 2.15
The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med (2013) 2.00
Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer (2002) 1.98
Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer (2010) 1.97
Delirium in advanced cancer patients. Palliat Med (2004) 1.92
Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol (2012) 1.86
Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med (2008) 1.76
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain (2006) 1.72
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila) (2011) 1.70
Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med (2005) 1.67
Patient-physician communication about code status preferences: a randomized controlled trial. Cancer (2013) 1.66
NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw (2009) 1.66
Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist (2011) 1.61
Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol (2013) 1.59
An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer (2010) 1.59
The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med (2010) 1.57
Palliative management of fatigue at the close of life: "it feels like my body is just worn out". JAMA (2007) 1.57
Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer (2015) 1.56
Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol (2004) 1.55
Inpatient rehabilitation improved functional status in asthenic patients with solid and hematologic malignancies. Am J Phys Med Rehabil (2011) 1.54
Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study. J Pain Symptom Manage (2005) 1.52
An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol (2004) 1.52
Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer (2014) 1.49
Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol (2013) 1.48
Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center. J Palliat Med (2010) 1.48
Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol (2006) 1.45
Cancer patients' perceptions regarding the value of the physical examination: a survey study. Cancer (2014) 1.44
Place of death of Houston area residents with cancer over a two-year period. J Pain Symptom Manage (2003) 1.44
The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. J Palliat Med (2014) 1.39
Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage (2010) 1.37
Access to palliative care among patients treated at a comprehensive cancer center. Oncologist (2012) 1.34
Place of death and its predictors for local patients registered at a comprehensive cancer center. J Clin Oncol (2002) 1.34
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med (2007) 1.32
Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol (2004) 1.32
Quantity, design, and scope of the palliative oncology literature. Oncologist (2011) 1.32
The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage (2011) 1.30
Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol (2013) 1.30
Pain and emotional distress in leukemia patients at diagnosis. Leuk Res (2009) 1.26
Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer (2004) 1.25
The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist (2011) 1.24
A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician (2012) 1.24
Spirituality, religiosity, and spiritual pain in advanced cancer patients. J Pain Symptom Manage (2011) 1.23
Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage (2012) 1.22
Symptom control in palliative care--Part II: cachexia/anorexia and fatigue. J Palliat Med (2006) 1.22
Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother (2004) 1.22
Assessing hope at the end of life: validation of an experience of hope scale in advanced cancer patients. Palliat Support Care (2004) 1.20
Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care (2008) 1.20
Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol (2007) 1.20
Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer (2009) 1.20
Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol (2011) 1.20
Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol (2008) 1.19
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer (2010) 1.19
Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med (2009) 1.18
Understanding the role of physician assistants in oncology. J Oncol Pract (2009) 1.18
A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer (2011) 1.17
Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med (2008) 1.17
Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol (2003) 1.16
Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med (2008) 1.15
Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer (2014) 1.14
Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med (2007) 1.14
NOPPAIN: a nursing assistant-administered pain assessment instrument for use in dementia. Dement Geriatr Cogn Disord (2004) 1.14
Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer (2009) 1.13
Symptom control in palliative care--Part III: dyspnea and delirium. J Palliat Med (2006) 1.13
Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer (2004) 1.12
A randomized, controlled trial of physician postures when breaking bad news to cancer patients. Palliat Med (2007) 1.12
Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med (2008) 1.12
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. J Clin Endocrinol Metab (2012) 1.11
Opioid switching: a systematic and critical review. Cancer Treat Rev (2006) 1.10
Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. J Palliat Med (2013) 1.10
The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med (2009) 1.09
Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab (2013) 1.08